178
E. Naimi et al.
2. Sorger, D.; Patt, M.; Kumar, P.; Wiebe, L.I.; Barthel, H.; Seese, A.; Dannenberg, C.; Tannapfel, A.; Kluge, R.;
Sabri, O. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a
comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
Nucl. Med. Biol. 2003, 30, 317–326.
3. Mannan, R.H.; Somayaji, V.V.; Lee, J.; Mercer, J.R.; Chapman, J.D.; Wiebe, L.I. Radioiodinated 1-(5-Iodo-5-
deoxy-b-D-arabinofuranosyl)-2-nitroimidazole (Iodoazomycin Arabinoside:IAZA): a novel marker of tissue
hypoxia. J. Nucl. Med. 1991, 32, 1764–1770.
4. Urtasun, R.C.; Parliament, M.B.; McEwan, A.J.; Mercer, J.R.; Mannan, R.H.; Wiebe, L.I.; Morin, C.;
Chapman, J.D. Measurement of hypoxia in human tumors by non-invasive SPECT imaging of azomycin
arabinoside. Br. J. Cancer., Suppl. 1996, 27, S209–S212.
5. Vinjamuri, S.; O’Driscol, K.; Maltby, P.; McEwan, A.J.; Wiebe, L.I.; Critchley, M. Identification of hypoxic
regions in traumatic brain injury. Clin. Nucl. Med. 1999, 24, 891–892.
6. Kumar, P.; Ohkura, K.; Beiki, D.; Wiebe, L.I.; Seki, K. Synthesis of 1-b-D-(5-deoxy-5-iodoarabinofuranosyl)-
2-nitoimidazole (b-IAZA): A novel marker of tissue hypoxia. Chem. Pharm. Bull. (Tokyo) 2003, 51, 399–
403.
7. Kumar, P.; Wiebe, L.I.; Atrazheva, E.; Tandon, M. An improved synthesis of a-AZA, a-AZP and a-AZG, the
precursors to clinical markers of tissue hypoxia. Tetrahedron Lett. 2001, 42, 2077–2078.
8. Baker, R.B.; Joseph, J.P.; Schraub, R.E. Puromycin. Synthetic studies. XIV. Use of the N-phthalyl blocking
group for synthesis of aminonucleosides. J. Am. Chem. Soc. 1955, 77, 5905–5910.
9. Glaudemans, C.P.J.; Fletcher, H.G., Jr. Syntheses with partially benzylated sugars. III. 1A simple pathway to a
‘‘cis-nucleoside,’’ 9-b-D-arabinofuranosyladenine (Spongoadenosine). J. Org. Chem. 1963, 28, 3004–3006.
10. Kumar, P.; Wiebe, L.I. Unpublished.
11. Nakajima, N.; Horita, K.; Abe, R.; Yonemitsu, O. MPM (4-methoxybenzyl) protection of hydroxyl functions
under mild acidic conditions. Tetrahedron Lett. 1988, 29, 4139–4142.
12. Schneider, R.F.; Engelhardt, E.L.; Stobbe, C.X.C.; Fenning, M.C.; Chapman, J.D. The synthesis and
radiolabeling of novel markers of tissue hypoxia of the iodinated azomycin nucleoside class. J. Labelled
Compd Radiopharm. 1997, 39, 541–557.
13. Lemieux, R.U.; Morgan, A.R. Mechanisms for reactions of anomeric tetra-O-acetyl-D-glucopyranosyl
bromides with pyridine and 2-pyridones. Can. J. Chem. 1965, 43, 2214–2218.
14. Prisbe, E.J.; Verheyden, J.P.H.; Moffat, J.G. 5-Aza-7-deazapurine Nucleosides. 2. 1Synthesis of some 8-(D-
ribofuranosyl)imidazo[1,2-a]-1,3,5-triazine derivatives. J. Org. Chem. 1978, 43(25), 4784–4794.
15. Baker, B.R.; Schaub, R.E.; Kissman, H.M. Puromycin. Synthetic Studies XV. 3’-Amino-3’-deoxyadenosine.
J. Am. Chem. Soc. 1955, 77, 5911–5915.
16. Fletcher, H.G. In Methods in Carbohydrate Chemistry. Whistler, R.L., Wolfrom, M.L., Eds.; Academia Press:
New York, 1992, 228.